univstats

Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) - Federal Grants

Funding Opportunity Overview

Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) is a Discretionary grant funded by National Institutes of Health. It is categorized in Health. The grants is open to all (government, organization, and/or individual) entities. The application deadline (close date) to apply is 2022-08-11 (-46 days left).
The following table summarizes the Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) opportunity.
Opportunity NumberRFA-DA-23-014
Opportunity TitleAvenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
Opportunity CategoryDiscretionary
Funding Instrument TypeGrant
Post DateMarch 21, 2022 (Monday)
Last Updated DateMarch 21, 2022 (Monday)
Close DateAugust 11, 2022 (Thursday)

Funding Detail Description

oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field.
In recent years, there have been significant advances in methods and technologies for the identification of novel targets, mechanisms, and pathways of interest to substance use disorders and in identification of probes and optimized compounds for developing novel therapeutic agents.

Dates and Awards Details

The following table shows the dates and awards information in detail for Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) federal grants. It posted on 2022-03-21 and will be closed on 2022-08-11.
Agency NameNational Institutes of Health
Important Dates
Post DateMarch 21, 2022 (Monday)
Close DateAugust 11, 2022 (Thursday)
Last Updated DateMarch 21, 2022 (Monday)
Archive DateSeptember 16, 2022 (Friday)
Awards DetailNot Available
Cost Sharing or Matching RequirementNo
Additional Information URLhttp://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-014.html

CFDA Numbers

The next CFDA (Catalog of Federal Domestic Assistance) numbers are associated to this federal grant.
  • 93.279 - Drug Abuse and Addiction Research Programs

Categories of Funding Activities

  • Education
  • Health
  • No Additional Explanation Reported

Funding Eligibility

Eligible Applicants:
  • State governments
  • Additional Information: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Grantor Contact Information

Grantor DetailNIH OER Webmaster
OERWebmaster03@od.nih.gov
EmailOERWebmaster03@od.nih.gov
(See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.)